XML 42 R32.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2017
Stock-Based Compensation Expense

The following table presents stock-based compensation expense included in the Company’s consolidated statements of comprehensive income (loss):

 

     Three Months Ended
March 31,
 
     2017      2016  

Cost of product revenue

   $ 141      $ 60  

Research and development

     132        80  

Selling, general and administrative

     1,258        782  
  

 

 

    

 

 

 

Total

   $ 1,531      $ 922  
  

 

 

    

 

 

 
Summary of Option Activity

Information regarding option activity for the three months ended March 31, 2017 under the Plans is summarized below:

 

     Options
Outstanding
     Weighted-
Average
Exercise
Price Per
Share
     Weighted-
Average
Remaining
Contractual
Term
(in years)
     (in thousands)
Aggregate
Intrinsic
Value
 

Options outstanding at December 31, 2016

     882,748      $ 16.88        

Granted

     86,215        32.40        

Exercised

     (137,903      9.67        

Forfeited/cancelled

     (25,157      21.31        
  

 

 

          

Options outstanding at March 31, 2017

     805,903      $ 19.68        7.08      $ 12,706  
  

 

 

          

Options exercisable at March 31, 2017

     406,859      $ 14.18        5.73      $ 8,659  
  

 

 

          

Vested and expected to vest at March 31, 2017 (1)

     791,227      $ 19.57        7.05      $ 12,530  
  

 

 

          

 

(1)  Represents the number of vested options as of March 31, 2017 plus the number of unvested options expected to vest as of March 31, 2017 based on the unvested outstanding options at March 31, 2017 adjusted for estimated forfeiture rates of 8% for awards granted to non-executive level employees and 3% for awards granted to executive level employees.
Summary of Restricted Stock Unit Activity

Information regarding restricted stock unit activity for the three months ended March 31, 2017 under the Plans is summarized below:

 

     Options
Outstanding
     Weighted-
Average
Exercise
Price Per
Share
     Weighted-
Average
Remaining
Contractual
Term
(in years)
     (in thousands)
Aggregate
Intrinsic
Value
 

Restricted stock units outstanding at December 31, 2016

     353,838      $ —          

Granted

     125,067        —          

Exercised

     (63,811      —          

Forfeited/cancelled

     (10,313      —          
  

 

 

          

Restricted stock units outstanding at March 31, 2017

     404,781      $ —          3.12      $ 14,248  
  

 

 

          

Vested and expected to vest at March 31, 2017 (1)

     378,579      $ —          3.01      $ 13,326  
  

 

 

          

 

(1)  Represents the number of vested restricted stock units as of March 31, 2017 plus the number of unvested restricted stock units expected to vest as of March 31, 2017 based on the unvested outstanding restricted stock units at March 31, 2017 adjusted for estimated forfeiture rates of 8% for awards granted to non-executive level employees and 3% for awards granted to executive level employees.